Alcaftadine Eye Drops For Allergies Available OTC In US With Allergan’s Lastacaft Launch

Abbvie business starts sales of Lastacaft (alcaftadine solution/0.25%) eye drops, licensed from innovator Vistakon Pharmaceuticals, approved through an sNDA. Full switch removes Lastacaft from Rx sales in US.